BioSpace News Archive

Mainz Biomed NV announced that it has entered into a $50 million Pre-Paid Advance Agreement with Yorkville Advisors Global, LP, a global investment management firm.

Eli Lilly and Company and Sigilon Therapeutics, Inc. announced a definitive agreement for Lilly to acquire Sigilon, a biopharmaceutical company that seeks to develop functional cures for patients with a broad range of acute and chronic diseases.

BioNTech SE and OncoC4, Inc. announced that the first patient with non-small cell lung cancer has been treated in a pivotal Phase 3 trial evaluating the companies’ next-generation anti-CTLA-4 antibody candidate BNT316/ONC-392.

Alaunos Therapeutics, Inc. today announced that the Company will present at the 2nd Hawaii Global Summit on Thoracic Malignancies taking place June 27 – July 1, 2023.

Immunome and Morphimmune, a private biotechnology company focused on developing targeted oncology therapeutics, announced that they have entered into a definitive merger agreement.

Rapport Therapeutics, Inc. today announced the formation of a scientific advisory board comprised of distinguished experts in medicinal chemistry.

Updated results from the HIMALAYA Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) demonstrated a sustained, clinically meaningful overall survival (OS) benefit at four years for patients with unresectable hepatocellular carcinoma (HCC) who had not received prior systemic therapy and were not eligible for localized treatment.

Genelux Corporation (NASDAQ: GNLX) and TVAX Biomedical, Inc. today announced that the United States Patent and Trademark Office granted a patent claiming methods of combining vaccine-enhanced adoptive T cell therapy with oncolytic virus adjunct therapy.

Rivus Pharmaceuticals Inc. today announced the appointment of Jayson Dallas, M.D., executive chairman for Rivus Pharmaceuticals, as Chief Executive Officer.

Abbott (NYSE: ABT) will announce its second-quarter 2023 financial results on Thursday, July 20, before the market opens.